针对Plasmodium中的第二阶段解毒酶抑制,用于治疗疟疾
Olalekan Onisuru1, Ikechukwu Achilonu1
1Protein Structure-Function Research Laboratory, School of Molecular and Cell Biology, Faculty of Science, University of the Witwatersrand, Braamfontein, Johannesburg, 2000, South Africa.
Biochemical and biophysical research communications
|September 18, 2025
概括
疟疾寄生虫通过逃避治疗而抵抗药物. 向Glutathione S-Transferase (GST) 提供了一种通过抑制寄生虫排毒机制来开发新的抗疟药物的新方法.
科学领域:
- 寄生虫学的寄生虫学
- 药物发现 药物发现 药物发现
- 生物化学 生物化学
背景情况:
- 尽管进行了广泛的研究,疟疾仍然是全球卫生挑战.
- 虫寄生虫对现有的抗疟疾药物产生耐药性,需要新的治疗策略.
- 了解寄生虫的新陈代谢对于识别新的药物点至关重要.
研究的目的:
- 为了探索抑制Plasmodium的Glutathione S-Transferase (GST) 作为一种潜在的抗疟疾药物发现途径.
- 突出GST在寄生虫生存和排毒中的关键作用.
- 审查GST在第二阶段生物转化中的功能,以寻求潜在的治疗干预.
主要方法:
- 对有关虫寄生虫和Glutathione S-Transferase的现有文献的综述.
- 对GST在异生物代谢和排毒途径中的作用的分析.
- 探索针对Plasmodium GSTs的抑制策略.
主要成果:
- 谷氨S转移酶 (GST) 在菌寄生虫的生存中起着至关重要的作用.
- GST有助于对寄生虫内的各种物质进行排毒.
- 抑制GST为抗疟疾药物开发提供了一个新的战略.
结论:
- 向Plasmodium falciparum和vivax GSTs为新的抗疟疾疗法提供了一个有希望的途径.
- 抑制GST可以克服现有的抗药性机制.
- 为了有效治疗疟疾,需要对GST抑制剂进行进一步的研究.
关键词:
排毒 排毒 排毒 排毒药物 药物 药物 药物 药物这是一个falciparum.谷氨S转移酶 (GST) 是一种抑制抑制的抑制作用疟疾:疟疾是一种疾病.流感病毒 (Plasmodium) 是一种病毒.维瓦克斯 (Vivax) 是一个更多相关视频
09:13Author Spotlight: Identifying Compensatory Pathways in Malaria Parasites Containing Hypomorphic Allele of Essential Protein Kinases
Published on: November 22, 2024
1.8K
05:28Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors
Published on: May 12, 2022
3.6K
相关概念视频
01:14Drug Metabolism: Phase II Reactions
4.9K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
4.9K
01:22Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation
833
Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
833
01:19Phase II Reactions: Miscellaneous Conjugation Reactions
361
Phase II biotransformations are detoxification mechanisms that conjugate xenobiotics with endogenous substances, neutralizing their toxicity.
A key example involves the conjugation of cyanide ions, which impair cellular respiration and alter hemoglobin into non-oxygen-carrying cyanmethemoglobin. To neutralize this threat, a sulfur atom from thiosulphate is transferred to the cyanide ion, catalyzed by the enzyme rhodanese, resulting in an inactive compound called thiocyanate. The production of...
A key example involves the conjugation of cyanide ions, which impair cellular respiration and alter hemoglobin into non-oxygen-carrying cyanmethemoglobin. To neutralize this threat, a sulfur atom from thiosulphate is transferred to the cyanide ion, catalyzed by the enzyme rhodanese, resulting in an inactive compound called thiocyanate. The production of...
361
01:24Phase II Reactions: Glucuronidation
1.6K
Glucuronidation, a pivotal phase II biotransformation process, involves the coupling of glucuronic acid to a drug or xenobiotic. Given its widespread occurrence and critical role in drug metabolism, it's considered the most crucial phase II reaction. It enhances the water solubility of substances, aiding their expulsion from the body. The driving force behind these reactions is a group of enzymes known as UDP-glucuronosyltransferases (UGTs). UGTs facilitate the transfer of a glucuronic acid...
1.6K
01:14Phase II Conjugation Reactions: Overview
768
Conjugation, a key component of phase II biotransformation reactions, is a vital process in drug detoxification. It involves transferring endogenous substances like glucuronic acid, sulfate, and glycine to drugs or their metabolites formed in phase I reactions. These conjugation reactions, often catalyzed by specific enzymes, transform potentially harmful metabolites into inactive, water-soluble forms easily excreted in urine or bile. By enhancing polarity and eliminating pharmacological...
768
01:17Phase II Reactions: Methylation Reactions
680
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
680